logo
Select company
Select metric
$ 0Capital Expenditure
VS
Market
86
Sector
77
Industry
91
History
6
$ 2.43Close
$ 2 - $ 29.07 52-Week Range
Ticker Information

Ticker

BBLG

Company Name

BONE BIOLOGICS CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

BONE BIOLOGICS CORP - Capital Expenditure Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BBLG - CapEx Historical data
DateCapital Expenditure
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BONE BIOLOGICS CORP's latest trailing twelve months (TTM) CapEx stands at $ 0.
  • Over the past 5 years, BONE BIOLOGICS CORP's average CapEx has been $ 0.
  • The median CapEx for BONE BIOLOGICS CORP during this period was $ 0
  • BONE BIOLOGICS CORP reached its highest CapEx over the past 5 years at $ 0.
  • The lowest CapEx recorded by BONE BIOLOGICS CORP in the same timeframe $ 0

Definition of Capital Expenditure

[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.

BBLG - Capital Expenditure, Last 5 years

$ 0

Minimum

Dec 31, 2020

$ 0

Maximum

Dec 31, 2020

$ 0

Average

$ 0

Median

CapEx Benchmark Analysis

The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.73M with a standard deviation of $ 15.95M.
The following table provides additional summary stats:
CapEx in the Market:
filtered constituents2.92K
min$ -41.06M
max$ 63.95M
average$ 9.73M
median$ 1.95M
std$ 15.95M